Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
M03BX01
|
| gptkbp:CASNumber |
1134-47-0
|
| gptkbp:contraindication |
hypersensitivity to baclofen
|
| gptkbp:developedBy |
gptkb:Ciba-Geigy
|
| gptkbp:discoveredIn |
1962
|
| gptkbp:hasInChIKey |
QNAYBMKLOCPYGJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C10H12ClNO2
|
| gptkbp:hasSMILES |
Clc1ccc(cc1)C[C@H](N)CO2
|
| gptkbp:hasUNII |
H789N3FKE8
|
| https://www.w3.org/2000/01/rdf-schema#label |
D00221
|
| gptkbp:KEGGID |
gptkb:D00221
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
GABA_B receptor agonist
|
| gptkbp:molecularWeight |
213.661 g/mol
|
| gptkbp:name |
gptkb:Baclofen
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL809
2284 DB00181 |
| gptkbp:routeOfAdministration |
oral
intrathecal |
| gptkbp:sideEffect |
dizziness
drowsiness weakness |
| gptkbp:synonym |
gptkb:Gablofen
gptkb:Lioresal gptkb:Kemstro |
| gptkbp:usedFor |
muscle spasticity
|
| gptkbp:bfsParent |
gptkb:N-acetylcysteine
|
| gptkbp:bfsLayer |
6
|